5.2 Influenza, Pneumococcal & COVID-19 Program

National Advisory Committee on Immunization Seasonal Influenza Statement for 2023/2024

National Advisory Committee on Immunization: COVID-19

Seasonal Flu Information for Health Professionals

COVID-19 Information for Health Professionals

Manitoba's 2023/24 Seasonal Influenza and COVID-19 Immunization Program Plan

Flu and COVID-19 Program Recap 2023

MEMO Re: Updated Respiratory Virus Guidance for Health Care Workers

Eligibility Criteria

1. Manitoba Health Eligibility Criteria for Influenza Vaccine 
2. Manitoba Health eligibility criteria for Pneumococcal Polysaccharide vaccine (PPV-23)
3. Manitoba Health Eligibility Criteria for COVID-19 Vaccine

Manitoba Health Seasonal Flu & COVID-19 Resources

1. Manitoba Health Seasonal Flu Resources
2. Seasonal Flu and COVID-19 Vaccine Distribution and Supply
3. 2023/24 COVID-19 and Influenza Immunization Program: Combined Vaccine Ordering and Delivery Model
4. 2023/24 Influenza and Pneumococcal Information Resources Order Form

Fact Sheets

1. Manitoba's Seasonal Influenza Immunization Program – Questions and Answers Fact Sheet: English version | French version
2. Seasonal Influenza Vaccine: English version | French version
3. Pneumococcal Polysaccharide Vaccine: English version | French version
4. High Dose Seasonal Influenza Vaccine for Eligible Seniors Aged 65 Years and Older: English Version | French Version
5. COVID-19 Vaccine Fact Sheets
   • COVID-19 mRNA Vaccine Information for Children Six Months to Four Years (updated Sept 2023)
   • COVID-19 mRNA Vaccine Information for Individuals aged 5 years and older (updated Sept 2023)
   • (Novavax/Nuvaxoid TM) COVID-19 Vaccine Information for Adults (Updated Dec 2022)
   • COVID-19 Vaccine: Information for Individuals who have an Autoimmune Condition and/or who are immunocompromised (updated Sept 2023)
   • COVID-19 Vaccine: Information for Individuals who are planning to get pregnant, currently pregnant, or breastfeeding (Updated Sept 2023)
   • COVID-19 Reaction Factsheet (Updated October 2021)
6. Manitoba's Pneumococcal Immunization Program – Q & A for HCPs

Product Monographs

• Afluria Tetra
• Fluzone Quadrivalent
• Flulaval Tetra
• Fluzone High Dose
• Pneumovax 23
• COVID-19 Vaccines
  • Pfizer-BioNTech XBB.1.5 COVID-19 Vaccine (Comirnaty ^TM)
  • Moderna XBB.1.5 COVID-19 Vaccine (Spikevax ^TM)
  • Novavax COVID-19 Vaccine (Nuvaxovid ^TM)

WRHA Influenza and Pneumococcal & COVID-19 Resources – Forms

i. Influenza, Pneumococcal & COVID-19 Immunization Consent form:

• English Letter Size
• English Legal Size
• French Letter Size

ii. Second dose reminder letter: English | French

iii. 2023-24 Immunization Advertising Tools

• Poster 11×17: English | French
• Poster 11×17 Fillable: English | French

Quick Reference Guides

1. Influenza Vaccine and Pneumococcal Polysaccharide Vaccine Quick Reference Guide 2023-2024
2. COVID-19 Quick Reference Guide
3. COVID-19 Vaccine Comparison Chart
4. Screening Questions for Influenza and Pneumococcal Vaccine 2023-2024
5. Storage and Handling Quick Reference for Manitoba's COVID-19 Vaccines

Training

• Manitoba Health Seasonal Influenza Vaccine Administration Training 2023/2024
• Training for COVID-19

Informed Consent

• Informed Consent for Immunization
• Informed Consent (for Procedures, treatments and Investigations)
  • Note Section 2.2 Decision Making Capacity

Surveillance

1. Influenza Immunization Monitoring Protocol
2. Immunization Inputting Form for Health Care Providers
3. Influenza and Pneumococcal Immunization Report and Invoice 2023

Additional Resources/Websites

1. Immunize.ca
2. Public Health Agency of Canada – Influenza
3. Fluwatch

Back to Section 05 – Population Public Health Program Specific Information

Back to Table of Contents